WELL, AN ASSISTANT PROFESSOR AT THE UNIVERSITY OF NEW MEXICO HAS JUST RECEIVED A GRANT TO CONDUCT MORE RESEARCH ON THE ...

Little is known about what causes ovarian cancer, and there is no way to detect it early yet. About 75% of the time when ...

Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...

Obesity, a growing global epidemic, is identified as a significant, modifiable risk factor for ovarian cancer, a deadly ...

In a pilot programme involving 840 patients with various cancers, the test successfully categorised individuals as either ...

Anixa Biosciences advances CAR T-cell therapy for recurrent ovarian cancer, targeting FSHR with promising safety and efficacy ...

Tennis legend Chris Evert, a two-time ovarian cancer survivor, is advocating for awareness and genetic screening after her ...

The USFDA approved the abbreviated new drug application for Doxorubicin Hydrochloride Liposome injection and single-dose ...

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...